有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | [(2R)-2,3-dihydro-1-benzothiophen-2-yl]-[(2R)-2-(1-methylpyrazol-4-yl)pyrrolidin-1-yl]methanone | —— | C17H19N3OS |
|
—— | [(2S)-2,3-dihydro-1-benzothiophen-2-yl]-[(2R)-2-(1-methylpyrazol-4-yl)pyrrolidin-1-yl]methanone | —— | C17H19N3OS |
|
—— | [(2R)-2,3-dihydro-1-benzothiophen-2-yl]-[(2S)-2-(1-methylpyrazol-4-yl)pyrrolidin-1-yl]methanone | —— | C17H19N3OS |
|
—— | 1-[(4-methylsulfanylphenyl)methyl]-3-[(1S)-1-(1,3,5-trimethylpyrazol-4-yl)ethyl]urea | —— | C17H24N4OS |
|
—— | 2-[3-(4-Chlorophenyl)sulfanylpropylazaniumyl]ethyl-dimethylazanium | —— | C13H23ClN2S+2 |
|
—— | Dimethyl-[2-[3-(4-methylphenyl)sulfanylpropylazaniumyl]ethyl]azanium | —— | C14H26N2S+2 |
|
—— | [(1S)-3-methyl-1-[5-[(4-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]butyl]azanium | —— | C15H22N3OS+ |
|
—— | 5-(5-Benzylsulfanyl-1,3,4-oxadiazol-2-yl)pentylazanium | —— | C14H20N3OS+ |
|
—— | 2-(4-methylphenyl)sulfanyl-N-(2,2,6,6-tetramethylpiperidin-1-ium-4-yl)acetamide | —— | C18H29N2OS+ |
|
—— | [(1S,2R)-1-[5-[(3-chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]azanium | —— | C14H19ClN3OS+ |
|
—— | tert-butyl N-[(1S)-1-[5-[(4-fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylpropyl]carbamate | —— | C18H24FN3O3S |
|
—— | 5-[5-[(4-Chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]pentylazanium | —— | C14H19ClN3OS+ |
|
—— | [(1S)-2-methyl-1-[5-[(2-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]propyl]azanium | —— | C14H20N3OS+ |
|
—— | [(1S,2R)-1-[5-[(2-fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]azanium | —— | C14H19FN3OS+ |
|
—— | [(1S,2S)-2-methoxycyclopentyl] 3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)propanoate | —— | C16H24N2O3S |
|
—— | [(1S)-1-(5-benzylsulfanyl-1,3,4-oxadiazol-2-yl)-2-methylpropyl]azanium | —— | C13H18N3OS+ |
|
—— | [(1S)-3-methyl-1-[5-[(2-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]butyl]azanium | —— | C15H22N3OS+ |
|
—— | 1-[(4-methylsulfanylphenyl)methyl]-3-[(1R)-1-(1,3,5-trimethylpyrazol-4-yl)ethyl]urea | —— | C17H24N4OS |
|
—— | 5-[(6-methoxypyridin-2-yl)methylsulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]-1,3,4-thiadiazol-2-amine | —— | C14H18N4O2S2 |
|
—— | 5-[(6-methoxypyridin-2-yl)methylsulfanyl]-N-[[(2R)-oxolan-2-yl]methyl]-1,3,4-thiadiazol-2-amine | —— | C14H18N4O2S2 |
|
—— | [(1S,2S)-2-methoxycyclopentyl] 3-cyclopentylsulfonylpropanoate | —— | C14H24O5S |
|
—— | 4-[4-(furan-2-yl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfanyl-N-[(2R)-1-methoxypropan-2-yl]butanamide | —— | C17H20F3N3O3S |
|
—— | (2S)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]propanoate | —— | C11H9N2O3S- |
|
—— | 4-[4-(furan-2-yl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfanyl-N-[[(2R)-oxolan-2-yl]methyl]butanamide | —— | C18H20F3N3O3S |
|
—— | N-[(2R)-butan-2-yl]-4-[4-(furan-2-yl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfanylbutanamide | —— | C17H20F3N3O2S |
|
—— | 4-[4-(furan-2-yl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfanyl-N-[[(2S)-oxolan-2-yl]methyl]butanamide | —— | C18H20F3N3O3S |
|
—— | N-[(2S)-butan-2-yl]-4-[4-(furan-2-yl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfanylbutanamide | —— | C17H20F3N3O2S |
|
—— | N-[(1R,2S)-2-methylcyclohexyl]-2-phenylsulfanylacetamide | —— | C15H21NOS |
|
—— | 4-[4-(furan-2-yl)-6-(trifluoromethyl)pyrimidin-2-yl]sulfanyl-N-[(2S)-1-methoxypropan-2-yl]butanamide | —— | C17H20F3N3O3S |
|
—— | N-[(1S,2R)-2-methylcyclohexyl]-2-phenylsulfanylacetamide | —— | C15H21NOS |
|
—— | (3S)-3-methyl-N-[3-(1,3-thiazol-2-ylsulfanyl)propyl]piperidine-1-sulfonamide | —— | C12H21N3O2S3 |
|
—— | (3R)-3-methyl-N-[3-(1,3-thiazol-2-ylsulfanyl)propyl]piperidine-1-sulfonamide | —— | C12H21N3O2S3 |
|
—— | (2S)-N'-propanoyl-2-[[5-(propylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanehydrazide | —— | C11H19N5O2S2 |
|
—— | (2S)-2-methyl-N-[3-(1,3-thiazol-2-ylsulfanyl)propyl]piperidine-1-sulfonamide | —— | C12H21N3O2S3 |
|
—— | (2R)-N'-propanoyl-2-[[5-(propylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanehydrazide | —— | C11H19N5O2S2 |
|
—— | 2-(1-cyclopropyl-4-oxopyrimidin-2-yl)sulfanyl-N-[[(2R)-oxolan-2-yl]methyl]acetamide | —— | C14H19N3O3S |
|
—— | 2-(1-cyclopropyl-4-oxopyrimidin-2-yl)sulfanyl-N-[[(2S)-oxolan-2-yl]methyl]acetamide | —— | C14H19N3O3S |
|
—— | [2-[4-(2,5-Dimethylphenyl)sulfanylanilino]-2-oxoethyl] 3-aminopyrazine-2-carboxylate | —— | C21H20N4O3S |
|
—— | N-[(2S)-4-phenylbutan-2-yl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C22H29NOS |
|
—— | N-cycloheptyl-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C19H29NOS |
|
—— | 3-Methyl-7-[(2,3,5,6-tetramethylphenyl)sulfanylmethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one | —— | C18H20N2OS2 |
|
—— | N-cyclopentyl-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C17H25NOS |
|
—— | N-[2-(4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)ethyl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C17H22N2O2S3 |
|
—— | 1-[2,5-Dimethyl-1-(5-methyl-1,2-oxazol-3-yl)pyrrol-3-yl]-2-(2,3,5,6-tetramethylphenyl)sulfanylethanone | —— | C22H26N2O2S |
|
—— | N-[(2R)-4-phenylbutan-2-yl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C22H29NOS |
|
—— | N-[(1S)-1-phenylethyl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C20H25NOS |
|
—— | N-[(2S)-2-phenylpropyl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C21H27NOS |
|
—— | N-[(1S)-1-(1-adamantyl)ethyl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C24H35NOS |
|
—— | ethyl 2,4-dimethyl-5-[2-(2,3,5,6-tetramethylphenyl)sulfanylacetyl]-1H-pyrrole-3-carboxylate | —— | C21H27NO3S |
|
—— | ethyl N-[2-(2,3,5,6-tetramethylphenyl)sulfanylacetyl]carbamate | —— | C15H21NO3S |
|